In this article published in Pharma Focus Asia, Dr. Yun Lu (Navitas Life Sciences), Deepak Mukherjee (Roche) and Kavita Lamror (Maxis Clinical Sciences) discuss how RWE is shaping clinical trial design, operational strategies, patient inclusivity and post-market evaluation across the Asia-Pacific region.

What You’ll Discover in This Article

• RWE and the Evolution of Clinical Trial Design
• Addressing Operational Challenges in APAC
• Improving Patient Representation in Clinical Trials
• Strengthening Post-Market Safety Monitoring
• Integrating AI and Advanced Analytics
• Building the Future RWE Ecosystem

Dr. Yun Lu VP and Chief Science & Innovation Officer Navitas Life Sciences

Published by Pharma Focus Asia, March 2026

Fill out the form to download the complete article.

© 2026 Navitas Life Sciences | Privacy Policy